BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12081014)

  • 1. Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines.
    Murphy BR; Coelingh K
    Viral Immunol; 2002; 15(2):295-323. PubMed ID: 12081014
    [No Abstract]   [Full Text] [Related]  

  • 2. Influenza vaccines.
    Brede HD
    Int Arch Allergy Immunol; 1995 Dec; 108(4):318-20. PubMed ID: 7580301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Live influenza vaccine in the USSR: its development, study and practical use].
    Zhdanov VM; Aleksandrova GI; Gendon IuZ
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jul; (7):3-13. PubMed ID: 3529762
    [No Abstract]   [Full Text] [Related]  

  • 4. The development of live attenuated cold-adapted influenza virus vaccine for humans.
    Maassab HF; Bryant ML
    Rev Med Virol; 1999; 9(4):237-44. PubMed ID: 10578119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cold-adapted influenza viruses for use as live vaccines for man.
    Maassab HF; Heilman CA; Herlocher ML
    Adv Biotechnol Processes; 1990; 14():203-42. PubMed ID: 2222834
    [No Abstract]   [Full Text] [Related]  

  • 6. A review of attenuation of influenza viruses by genetic manipulation.
    Belshe RB
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 2):S72-5. PubMed ID: 7551418
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects.
    Treanor JJ; Betts RF
    Vaccine; 1998 Nov; 16(18):1756-60. PubMed ID: 9778752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of a live attenuated influenza B virus vaccine candidate.
    Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL
    Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reactogenicity, genetic stability and effectiveness of a live recombinant influenza vaccine for children designed on the base of a cold-adapted attenuation donor A/Leningrad/134/47/57].
    Aleksandrova GI; Medvedeva TE; Polezhaev FI; Garmashova LM; BudilovskiÄ­ GN
    Vopr Virusol; 1986; 31(4):411-4. PubMed ID: 2945324
    [No Abstract]   [Full Text] [Related]  

  • 10. [The immunogenic properties and prophylactic efficacy of a live polyvalent influenza vaccine in children 5 to 14 years old].
    Grigor'eva EP; Rekstin AR; Rudenko LG; Ramirez A; Barro M; Lisovskaia KV; Klimov AI; Aleksandrova GI
    Vopr Virusol; 1994; 39(1):26-9. PubMed ID: 8160445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines. Shifting tactics in the battle against influenza.
    Ault A
    Science; 2004 Feb; 303(5662):1280. PubMed ID: 14988531
    [No Abstract]   [Full Text] [Related]  

  • 12. Learning from our foes: a novel vaccine concept for influenza virus.
    Palese P; Muster T; Zheng H; O'Neill R; Garcia-Sastre A
    Arch Virol Suppl; 1999; 15():131-8. PubMed ID: 10470274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2014 Mar; 89(10):93-104. PubMed ID: 24707514
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial commentary: Changing epidemiology of influenza B virus.
    Glezen WP
    Clin Infect Dis; 2014 Dec; 59(11):1525-6. PubMed ID: 25139967
    [No Abstract]   [Full Text] [Related]  

  • 15. [Development of a live culture of cold-adapted reassortant influenza vaccines].
    Gendon IuZ; Markushin SG; Akopova II; Koptiaeva NB; Isachenko AA; Mazurkova NA; Nechaeva EA
    Vopr Virusol; 2003; 48(2):12-7. PubMed ID: 12924092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Basis of Attenuation of Cold-Adapted Influenza Strain B/Leningrad/14/17/55 - Backup Master Donor Virus for Influenza Type B Live Attenuated Vaccines.
    Krutikova EV; Stepanova EA; Wong PF; Kiseleva IV; Grigor'eva EP; Rudenko LG
    Bull Exp Biol Med; 2020 Mar; 168(5):669-672. PubMed ID: 32248454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommended composition of influenza virus vaccines for use in the 2003-2004 influenza season.
    Wkly Epidemiol Rec; 2003 Feb; 78(9):58-62. PubMed ID: 12666272
    [No Abstract]   [Full Text] [Related]  

  • 18. Influenza vaccine--outmaneuvering antigenic shift and drift.
    Treanor J
    N Engl J Med; 2004 Jan; 350(3):218-20. PubMed ID: 14724300
    [No Abstract]   [Full Text] [Related]  

  • 19. [New vaccines against influenza via inhalation].
    Domínguez A; Vidal J
    Aten Primaria; 1999 Oct; 24(6):313-5. PubMed ID: 10596220
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influenza live attenuated intra-nasal vaccines].
    Weil-Olivier C
    Arch Pediatr; 2010 Jun; 17(6):904-5. PubMed ID: 20654953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.